Brenner Tumor - 50 Studies Found Estado Estudiar Completed Nombre del estudio: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) Condición: Brenner Tumor Fallopian Tube Cancer Drug: carboplatin Given intrap Completed Nombre del estudio: Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condición: Brenner Tumor Fallopian Tube Cancer Procedure: adjuvant therapy Drug: paclitax Recruiting Nombre del estudio: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condición: Ovarian Brenner Tumor Ovarian Carcinosarcoma Drug: Gemcitabine Hydrochloride Completed Nombre del estudio: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer Condición: Malignant Ovarian Mixed Epithelial Tumor Ovarian Brenner Tumor< Fecha: 2011-02-10 Intervenciones: Drug: TLR8 Agonist VTX-2337 Gi Suspended Nombre del estudio: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer Condición: Nausea and Vomiting Ovarian Brenner Tumor Procedure: Adjuvant Therapy An Active, not recruiting Nombre del estudio: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condición: Malignant Ovarian Mixed Epithelial Tumor Ovarian Brenner Tumor< Fecha: 2009-08-01 Intervenciones: Biological: Bevacizumab Given Completed Nombre del estudio: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer Condición: Fallopian Tube Carcinoma Malignant Ovarian Mixed Epithelial Tumor Drug: Carboplatin Given IV Active, not recruiting Nombre del estudio: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Condición: Cognitive Side Effects of Cancer Therapy Malignant Ovarian Epithelial Tumor Procedure: Cognitive Assessment Completed Nombre del estudio: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condición: Fallopian Tube Carcinoma Malignant Ovarian Mixed Epithelial Tumor Biological: Urokinase-Derived Peptide A6 Recruiting Nombre del estudio: MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian Cancer Condición: Malignant Ovarian Brenner Tumor Ovarian Clear Cell Adenocarcino Fecha: 2014-02-19 Intervenciones: Other: Laboratory Biomarker Analysis <<< Previous | Next >>>